Presentation anfd conference call16 Aug 2019 13:17
I wonder if some significant news will be RNSed before?
TURKU - FINLAND, 16 August 2019 - Faron Pharmaceuticals Ltd ("Faron") (LON: FARN), the clinical stage biopharmaceutical company, will announce its unaudited interim results for the six months ended 30 June 2019 on Monday 23 September 2019.
Dr Markku Jalkanen, Chief Executive Officer, Toni Hänninen, Chief Financial Officer and Yrjö Wichmann, Vice President, Financing and Investor Relations will host a presentation and conference call for analysts at 9.30am BST on the day of the results at the offices of Panmure Gordon, One New Change, London, EC4M 9AF. Please contact Consilium Strategic Communications for further details.